Replies to post #110638 on Amarantus Bioscience Holdings Inc (AMBS)

[DCorleone]

So our 1M shares would become 10k. At today's price that would be around $8.20 a share. Your projection places the stock at 6.5 cents.
Your not expecting a small increase in share price due to the Nasdaq listing? I am not disagreeing with you, just in the past there is usually a bump in the beginning even if it were to go back down.

[myersvodka]

Wrong, please read the chairman's blog again.

[Rosym]

Gerald E. Commissiong - We recognize that it is not optimal to up list from a position of weakness, and therefore we will only consider an up list from a position of strength while the Company is making good progress in the market. We believe the milestones we’ve outlined above – for the end of 2014 alone – will put us in that position. However, if we do not believe we have achieved sufficient shareholder value creation, we will consider delaying the up list until such time as the market recognizes our true value.

He is waiting for the right time to Uplist without R/S.

[GS1]

Gerlad mentioned spinoff to shareholders. It means new diagnostic company publicly traded and shareholders of AMBS will get shares in newly formed company. There is no R/S for AMBS as AMBS will remain holding company.